Partnership agreement with veterinary services in Iceland

Previwo has recently entered into a collaboration agreement with the veterinary service provider VETAQ in Iceland.

- With this collaboration agreement, we are strengthening our presence in Iceland and will be able to offer even better support to our customers,” says Lars Kristian Bredahl, CEO of Previwo.

Previwo is a Norwegian biotechnology company that has developed a probiotic product to improve the health of farmed fish. While the company has primarily focused on the Norwegian market, demand for Previwo’s Stembiont® Vital has grown significantly in Iceland since 2024.

- Iceland has seen strong growth in aquaculture, and we are experiencing increasing demand for tools that can strengthen biology and fish health,” says Bredahl.

To provide closer support in Iceland, Previwo has now partnered with VETAQ.

- VETAQ shares our ambition to provide knowledge and support to an industry with significant potential. Proximity and local expertise are extremely valuable in biological production. Together, we can improve fish health and animal welfare in Iceland,” Bredahl adds.

A shared focus on fish health and welfare

VETAQ is the leading fish health service provider in Iceland, with many years of experience in the aquaculture industry in both Norway and Iceland.

- By combining knowledge from both the Norwegian and Icelandic aquaculture industries, we have a strong understanding of the complexity of health challenges in fish farming and how to prevent disease in fish populations,” says Dan Roger Lid, CEO of VETAQ.

VETAQ will support Previwo’s customers in Iceland with technical guidance and professional expertise to ensure the correct use of Stembiont® Vital.

- Previwo is an exciting company, built on strong values and broad expertise. VETAQ sees this collaboration as very positive, as we can contribute by ensuring that the product is used in a correct and responsible way, with fish health and welfare as the main priority,” Lid concludes.